You are here Biopharmaceutical Glossary Homepage/Search Index > Newest biopharmaceutical definitions 

 
 Newest biopharmaceutical definitions 
Evolving Terminology for Emerging Technologies
Comments? Questions? Revisions? Mary Chitty 
mchitty@healthtech.com
Last revised September 26, 2008
View a Printer-Friendly Version of this Web Page!


New Page 1

Please register for CHI's Genomics Glossaries & Taxonomies website. This sign-in box with then disappear from each page, if you accept cookies. Use of this site will continue to be free, but better demographic data on who is accessing this material helps us to justify the expense of maintaining this resource. Registration policy has details.

Registered users of the Genomics Glossaries & Taxonomies will automatically be signed up for CHI's complimentary email monthly newsletter, GenomeLink, unless you choose to opt out of receiving it.

Mr.     Ms.     Mrs.     Dr.     Prof.

First:

         

Last:

Title:

Dept.:

Company:

Address:

City:

State:

Zip:

Country:

Email:

Opt-out of Email

YES    NO

Telephone:

Would you like to receive CHI event updates via fax? 
Yes       No 

Fax:


21st century Drug discovery & development Map    Informatics map   Technologies map    Biology & chemistry map   Finding guide to terms in these glossaries   Site Map 
** newest of the new definitions

accelerator mass spectrometry: Mass spectrometry

adaptive clinical trials: Drug approvals and clinical trials

Bayesian clinical trials: Drug approvals and clinical trials

biological chemistry: Chemistry (& biology)

biomathematics Algorithms

biomedical polymers: Biomaterials

biomolecular screening: Assays & screening

chaperome: -Omes & -omics

cellular dielectric spectroscopy CDS: 

combination therapies:  Drug Discovery & Development

comparative systems biology: Genomic Manipulation & Disruption

computational physiology: In Silico & Molecular Modeling

computational sensing: Labels Signaling & detection

Copy Number Polymorphisms CNPs: SNPs and Genetic Variations

developability: Drug discovery & development 

diffusion tensor imaging: Molecular imaging

disproportionate drug metabolite: Drug safety, Pharmacovigilance & toxicology

drug metabolism: Pharmacogenomics

e-health: http://en.wikipedia.org/wiki/EHealth 

evidence based toxicology: Drug safety, Pharmacovigilance & toxicology

exploratory IND:  Drug approvals

expressomics: -Omes & -omics

follow-on drug: Drug discovery & development 

fragment based drug discovery  Assays and screening

genetic susceptibility: Molecular diagnostics -- genetic & genomic testing

GIS Geographic Information Systems: Molecular Medicine and Diagnostics

GSK: GlaxoSmithKline 

green chemistry: Chemistry & biology

inflammasome: -Omes & -omics

integrative and organ systems pharmacology: Pharmacogenomics 

** in vitro adventitious assays: Assays & screening   

in vitro diagnostic multivariate index assays IVDMIAs: Genetic & genomic testing

label free detection: Labels Signaling & detection

lead hopping: Assays

mass spectrometry" IUPAC Mass Spectrometry Standard definitions of terms relating to mass spectrometry Provisional recommendations, 2006 http://www.iupac.org/reports/provisional/abstract06/murray_prs.pdf  

materials chemistry: Chemistry & biology

medical resequencing: Sequencing

mesoscopic biology: Expression genes & proteins

metabolite: Drug safety, Pharmacovigilance & toxicology

microdosing Pharmacogenomics

mitochondriomics: -Omes & -omics

molecular biosensors: Labels Signaling & detection

molecular crowding: Biomolecules

molecular electronics: Nanoscience & miniaturization

molecular events: Cancer genomics

molecular pharmacology Pharmacogenomics

nanolabels: Labels Signaling & detection

nanomedicine: Nanoscience & miniaturization 

nanotechnology in the clinical laboratory setting: Molecular Medicine

natural competence: DNA

next generation sequencing: Sequencing

-Omes & -omics: Lots of new terms including alleome, chromatinomics, chromosonics, cryobionomics,
embryogenomics, epitomics, fragonomics, lectinomics, mitogenomics, Nobonomics, paleogenomics, RNome, RNomics, separomics, strainomics, transgenomics

pharmacokinetics pharmacodynamics: Pharmacogenomics

pharmacologically active metabolite: Drug safety, Pharmacovigilance & toxicology

Phase zero, Phase O: Drug approvals

pipeline problem:  Drug discovery

post-genomic chemistry: Chemistry & biology

predictive ADME: Drug safety & pharmacovigilance

predictive toxicology: Drug safety, toxicology & pharmacovigilance

process chemistry: Chemistry & biology 

Proteomic Standards Initiative: Proteomics

resourceome: -Omes & -Omics   

ridiculome: -Omes & -Omics

safety pharmacology: Drug Safety & Pharmacovigilance

solubility: Chemistry & biology

supramolecular electronics: Nanoscience & miniaturization

systems pharmacology: Pharmacogenomics

scaffold hopping: Chemistry

Sentinel Initiative: Drug safety, toxicology & pharmacovigilance

target hopping: Drug targets

therapeutic antibodies: Drug targets

top-down mass spectrometry: Mass spectrometry glossary

type 0, type I, type II biomarkers: Biomarkers

women's health: Molecular Medicine and Diagnostics

women's health statistical modeling: Molecular Medicine and Diagnostics

Bibliography
Alpha glossary index
How to look for other unfamiliar  terms

Contact | Privacy Statement | Alphabetical Glossary List | Tips & glossary FAQs | Site Map